Compare IPSC & AIRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IPSC | AIRE |
|---|---|---|
| Founded | 2019 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.3M | 56.9M |
| IPO Year | 2021 | N/A |
| Metric | IPSC | AIRE |
|---|---|---|
| Price | $0.92 | $0.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $3.00 | $2.00 |
| AVG Volume (30 Days) | 1.5M | ★ 6.1M |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $113,337,000.00 | $4,149,567.00 |
| Revenue This Year | $1,590.09 | $456.19 |
| Revenue Next Year | N/A | $105.16 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 4122.69 | 994.18 |
| 52 Week Low | $0.34 | $0.14 |
| 52 Week High | $1.19 | $2.29 |
| Indicator | IPSC | AIRE |
|---|---|---|
| Relative Strength Index (RSI) | 61.52 | 46.96 |
| Support Level | $0.91 | $0.40 |
| Resistance Level | $1.05 | $0.60 |
| Average True Range (ATR) | 0.12 | 0.04 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 66.72 | 27.74 |
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are; Platform Services and the Rental business segment.